Need professional-grade analysis? Visit stockanalysis.com
$79.84M
N/A
771
N/A
VITA 34 AG (V3V) trades on XETRA (Frankfurt) in EUR. The company is classified in the Healthcare sector under the Medical Care Facilities industry. The stock currently trades at EUR4.51, down 1.53% from the previous close.
Over the past year, V3V has traded between a low of EUR3.90 and a high of EUR7.45. The stock has gained 11.1% over this period. It is currently 39.5% below its 52-week high.
VITA 34 AG has a market capitalization of $79.84M.
FamiCord AG engages in the collection, processing, cryopreservation, and storage of stem cells from umbilical cord blood and tissue and postnatal tissue in Germany, Poland, Portugal, and internationally. It operates through Subgroup Vita 34 And Subgroup PBKM segments. The company produces and develops advanced therapies, genetic tests, and analyses for third parties. It also develops products and drugs based on cells, tissues, and blood for medical applications; and produces and manufactures viral vectors and CAR-T cells. In addition, the company provides biobanking services, such as freezing sperm and storage of adipose tissue and the isolation of cells from the stored materials. The company was formerly known as VITA 34 AG and changed its name to FamiCord AG in February 2025. FamiCord AG was founded in 1997 and is based in Leipzig, Germany.
Side-by-side comparison against top Healthcare peers.